RELPAX

This brand name is authorized in United States. It is also authorized in Australia, Austria, Canada, Croatia, France, Germany, Hong Kong SAR China, Ireland, Italy, Japan, Mexico, Netherlands, New Zealand, Poland, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug RELPAX contains one active pharmaceutical ingredient (API):

1	Eletriptan UNII M41W832TA3 - ELETRIPTAN HYDROBROMIDE
	Eletriptan is a selective agonist at the vascular 5-HT1B and neuronal 5-HT1D receptors. Eletriptan also exhibits high affinity for the 5-HT1F receptor which may contribute to its anti-migraine mechanism of action.
	Read more about Eletriptan

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
RELPAX Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02CC06	Eletriptan	N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CC Selective serotonin (5HT1) agonists
Discover more medicines within N02CC06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	5290K, 5291L
CA	Health Products and Food Branch	02256290, 02256304
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	01658658, 01658687, 03932804, 03932810, 03932827, 03932833, 03934306, 03934393, 06974714, 07005710, 09423179, 11689967, 12526902, 13332376, 13332382, 13781826, 14256789, 17448242
ES	Centro de información online de medicamentos de la AEMPS	64124, 64125
FR	Base de données publique des médicaments	63476564, 64350636
GB	Medicines & Healthcare Products Regulatory Agency	146202, 34000, 34036, 374138, 381652
HK	Department of Health Drug Office	66729
HR	Agencija za lijekove i medicinske proizvode	HR-H-319261647
IE	Health Products Regulatory Authority	54287, 72122
IT	Agenzia del Farmaco	035307103, 035307281, 035307305
JP	医薬品医療機器総合機構	2160005F1021
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	050M2000
NL	Z-Index G-Standaard, PRK	60232
NZ	Medicines and Medical Devices Safety Authority	8591, 8592, 8593
PL	Rejestru Produktów Leczniczych	100109142
SG	Health Sciences Authority	11767P, 11768P
TN	Direction de la Pharmacie et du Médicament	14573021
TR	İlaç ve Tıbbi Cihaz Kurumu	8699532090881, 8699532095176, 8699532096418
US	FDA, National Drug Code	0049-2330, 0049-2340, 63539-234
ZA	Health Products Regulatory Authority	34/7.3/0077, 34/7.3/0078, 34/7.3/0079